Interactions Between Anticancer Drugs and Other Clinically Used Pharmaceuticals: A Review

References

• Steel GG. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988; 11: 31
   PubMed Web of Science ®Google Scholar
• Di Marco A, Dasdia T, Pastori W. Interaction of calcium ions and CAMP on the cytotoxic effect of doxorubicin. Tumori 1984; 30: 217
   Google Scholar
• Ducore J M, Rosenstein BS. Theophylline reversal of alkylator-induced replican initiation inhibition: no correlation with DDP-induced cytotoxicity. Mutat Res 1984; 141: 117
   Google Scholar
• Ducore J M, Rosenstein BS. Theophylline release of replican initiation inhibition by nitrosoureas correlates with the synergistic killing in L1210 leukemia in vitro. Mutat Res 1985; 146: 1
   Google Scholar
• Bennett A, Gaffen J D, Melhuish P B, Stamford IF. Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate. Br J Pharmacol 1987; 91: 229
   Google Scholar
• Pozner J, Papatestas A E, Fagerstrom R, et al. Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. Surgery 1986; 100: 482
   Google Scholar
• Caffeine Timson J. Mutat Res 1977; 47: 1
   Google Scholar
• Cohen MH. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine. J Pharmacol Exp Ther 1975; 194: 475
   PubMedGoogle Scholar
• Osieka R, Glatte P, Pannenbacker R, Schmidt CF. Enhancement of semustine-induced cytotoxicity by chlorpromazine and caffeine in a human melanoma xenograft. Cancer Treat Rep 1986; 70: 1167
   PubMedGoogle Scholar
• Allen T E, Aliano N A, Cowan R J, et al. Amplification of the antitumor activity of phleomycins and bleomycins in rats and mice by caffeine. Cancer Res 1985; 45: 2516
   Google Scholar
• Basu T, Williams D. Accentuation of the cell-killing effects of chlorambucil by phenobarbital, caffeine and vitamin A in culture. Cytobios 1974; 9: 115
   Google Scholar
• Fraval H N, Roberts JJ. Effects of cis-platinum (II) diamine-dichloride on survival and the rate of DNA synthesis in synchronously growing Chinese hamster V79–379A cells in the absence and presence of caffeine inhibited post-replication repair; evidence for an inducible repair mechanism. Chem Biol Interact 1978; 23: 99
   Google Scholar
• Orstavik J. Caffeine sensitive recovery of mitomycin C treated mouse P-388 cells. Acta Pathol Microbiol Scand 1972; 80: 900
   Google Scholar
• Walker I G, Reid BD. Caffeine potentiation of the lethal action of alkylating agents on L-cells. Mutat Res 1971; 12: 101
   PubMedGoogle Scholar
• Cohen M H, Schoenfeld D, Wolter J. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma. Cancer Treat Rep 1980; 64: 151
   PubMedGoogle Scholar
• Miyamoto K, Matsunaga T, Waki Y, Koshiura R. Enhancement of mitomycin C uptake by isoproterenol in rat ascites hepatoma. J Pharmacobiodyn 1986; 9: 453
   Google Scholar
• Grzanna R, Frondoza C G, Hung G L, Sastre A. In vivo administration of propranolol delays development of a murine plasmacytoma tumor. Auton New Syst 1985; 14: 397
   Google Scholar
• Mattsson J, Appelgren L, Hamberger B, Peterson HI. Adrenergic innervation of tumor blood vessels. Cancer Lett 1977; 3: 347
   Web of Science ®Google Scholar
• Thom A K, Sigurdson E R, Ridge J A, Zhang S, Daly JM. Modulation of doxorubicin uptake by epinephrine in the VX-2 carcinoma. J Surg Res 1987; 42: 543
   Google Scholar
• Ziessman H A, Forastiere A A, Wheeler R H, et al. The use of a vasoconstrictor to improve tumour blood flow in intra-arterial chemotherapy: preliminary report. Nucl Med Commun 1985; 6: 777
   Google Scholar
• Matsuura H, Ikeda Y, Imaya H, Nakazawa S. Selective change of blood flow in experimental brain tumor with induced hypertension. Surg Neurol 1987; 27: 433
   Google Scholar
• Baba T, Taniguchi S. Improvement of cancer therapy by angiotensin II-induced hypertension chemotherapy. Gan To Kagaku Ryoho 1987; 14: 971
   Google Scholar
• Van Mouwerik T J, Pangallo C A, Willson J K, Fischer PH. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole. Biochem Pharmacol 1987; 36: 809
   Google Scholar
• Chaplin DJ. Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT). Br J Cancer 1986; 54: 727
   PubMedGoogle Scholar
• Chaplin D J, Acker B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain. Int J Radiat Oncol Biol Phys 1987; 13: 579
   PubMed Web of Science ®Google Scholar
• Shinozawa S, Gomita Y, Araki Y. Protection against adriamycin (doxorubicin)—induced toxicity in mice by several clinically used drugs. Acta Med Okayama 1987; 41: 11
   Google Scholar
• Guthrie D, Gibson AL. Doxorubicin cardiotoxicity—possible role of digoxin in its prevention. Br Med J 1977; 2: 1447
   Google Scholar
• Nierenberg D W, Mamelok RD. Toxic reaction to methotrexate in a patient receiving penicillin and furosemide: A possible interaction. Arch Dermatol 1983; 119: 449
   Google Scholar
• Verweij J, Kerpel-Fronius S, Stuurman M, de Vries J, Pinedo H. Absence of interaction between furosemide and mitomycin C. Cancer Treat Rep 1987; 19: 84
   Google Scholar
• Pera M T, Zook B C, Harder HC. Effect of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum- (II) in rats. Cancer Res 1979; 39: 1269
   PubMedGoogle Scholar
• Biaglow J E, Varnes M E, Jacobson B, Suit HD. Effect of calcium channel blocking drugs on tumor cell oxygen utilization. Adv Exp Med Biol 1986; 200: 583
   Google Scholar
• Morrow M, Wait R B, Rosenthal R A, Gamelli RK. Verapamil enhances antitumor activity without increasing myeloid toxicity. Surgery 1987; 101: 63
   Google Scholar
• Yalowich J C, Ross WE. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro. Cancer Res 1985; 45: 1651
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Naganuma K, Tsukagoshi S, Sakurai Y. Promotion by verapamil of vincristine responsiveness in tumour cell lines inherently resistant to the drug. Cancer Res 1983; 43: 808
   PubMed Web of Science ®Google Scholar
• Bellelli A, Camboni C, de Luca G, et al. In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine. Oncology 1987; 44: 17
   Google Scholar
• Lönn U, Lönn S. W-7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells. Int J Cancer 1987; 39: 638
   Google Scholar
• Smith P J, Mircheva J J, Bleehen NM. Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluorperazine. Acta Physiol Pharmacol Bulg 1987; 13: 41
   PubMedGoogle Scholar
• Wiegant F AC, Tuyl M, Linnemans W AM. Calmodulin inhibitors potentiate hyperthermia cell killing. Int J Hyperthermia 1985; 1: 157
   PubMedGoogle Scholar
• Keyes S R, Rockwell S, Sartorelli AC. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res 1985; 45: 213
   Google Scholar
• Zacharski LR. Basis for selection of anticoagulant drugs for therapeutic trials in human malignancy. Haemostasis 1986; 16: 300
   PubMedGoogle Scholar
• Kirsch W, Schulz D, Van Buskirk J, Young H. Effects of sodium warfarin and other carcinostatic agents on malignant cells: a study of drug synergy. J Med 1974; 5: 69
   Google Scholar
• Ghersa P, Donelli MG. Distribution and antitumoral activity of adriamycin combined with warfarin in mice. Cancer Che-mother Pharmacol 1980; 5: 43
   Google Scholar
• Nimmo WS. Drugs, diseases and altered gastric emptying. Clin Pharmacokinet 1976; 1: 189
   PubMedGoogle Scholar
• Kjellén E, Wennerberg J, Pero R. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck, Abstr 959 ECCO-4. Madrid. 1987
   Google Scholar
• Catino J J, Francher D M, Schurig JE. Evaluation of cisdiamrninedichloroplatinum(II) combined with metoclopramide or sodium thiosulfate on L1210 leukemia in vitro and in vivo. Cancer Chemother Pharmacol 1986; 18: 1
   PubMedGoogle Scholar
• Osborne R J, Slevin M L, Hunter R W, Hamer J. Cardiac arrhythmias during cytotoxic chemotherapy: Role of domperidone. Human Toxicol 1985; 4: 617
   PubMedGoogle Scholar
• Henriksson R, Grankvist K. Epirubicin cytotoxicity but not oxygen radical formation is enhanced by four different antiemetics. Med Oncol Tumor Pharmacother, in press
   Google Scholar
• Hande K, Combs G, Swingle R, Combs G L, Anthony L. Effect of cimetidine and ranitidine on the metabolism and toxicity of hexamethylmelamine. Cancer Treat Rep 1986; 70: 1443
   Google Scholar
• Dorr R T, Soble M J, Alberts DS. Interaction of cimetidine but not ranitidine with cyclophosphamide in mice. Cancer Res 1986; 46: 1795
   PubMed Web of Science ®Google Scholar
• Dorr R T, Alberts DS. Cimetidine enhancement of cyclophosphamide antitumor activity. Br J Cancer 1982; 45: 35
   Google Scholar
• Hess W A, Kornblith PL. Combination of lomustine and cimetidine in the treatment of a patient with malignant glioblastoma: a case report. Cancer Treat Rep 1985; 69: 733
   Google Scholar
• Volkin R L, Shadduck R K, Winkelstein A, Zeigler Z R, Selker RG. Potentiation of carmustine-cranial irradiation induced myelosuppression by cimetidine. Arch Intern Med 1986; 142: 243
   Google Scholar
• Said H M, Hollander D. Inhibitory effect of bile salts on the enterohepatic circulation of methotrexate in the unanesthetized rat: inhibition of methotrexate intestinal absorption. Cancer Chemother Pharmacol 1986; 16: 121
   Google Scholar
• Daly H, Boyle J, Roberts C, Scott G. Interaction between methotrexate and non-steroidal anti-inflammatory drugs. Lancet 1986; 1: 8480
   Google Scholar
• Singh R R, Malaviya A N, Pandey J N, Guleria JS. Fatal interaction between methotrexate and naproxen. Lancet 1986; 1: 3517
   Google Scholar
• Thyss A, Milano G, Kubar J, Namer M, Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986; 1: 256
   PubMed Web of Science ®Google Scholar
• Ellison N M, Servi RJ. Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU: A possible adverse effect due to concomitant indomethacin administration. Cancer Treat Rep 1984; 69: 342
   Google Scholar
• Badr M Z, Theresa SC. Potentiation of methotrexate-in-duced gastrointestinal toxicity by non-steroidal anti-inflammatory drugs (NSAIDs) and vincristine. Toxicology 1985; 29: 333
   Google Scholar
• Gewirtz D A, Holt SA. Protein binding as a component of drug interaction in cellular pharmacokinetic studies: effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in-vitro. Biochem Pharmacol 1985; 34: 747
   Google Scholar
• Gewirtz D A, Plotkin J H, Randolph JK. Interaction of probenecid with methorexate transport and release in the isolated rat hepatocyte in suspension. Cancer Res 1984; 44: 3846
   Google Scholar
• Weppelman B Z, Mönkemier D. The influence of prostaglandin antagonists on radiation therapy of carcinoma of the cevix. Gynecol Oncol 1984; 17: 196
   Google Scholar
• Rubio CA. Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer 1986; 58: 1029
   PubMed Web of Science ®Google Scholar
• Gaffen J D, Bennett A, Barer MR. A new method for studying cell growth in suspension, and its use to show that indomethacin enhances cell killing by methotrexate. J Pharm Pharmacol 1985; 37: 261
   Google Scholar
• Thrall R S, McCormick J R, Jack RM. Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol 1979; 95: 117
   PubMed Web of Science ®Google Scholar
• Goldenberg GJ. Drug-induced stimulation of nitrogen mustard and choline transport and other systems in L5178Y lymphoblasts. Cancer Res 1974; 34: 2511
   Google Scholar
• Goldenberg GJ. Drug-induced stimulation of transport of hydrolyzed nitrogen mustard and choline by normal an leukemic human cells in vitro. Cancer Res 1976; 36: 978
   Google Scholar
• Bruce D. Anesthetic-induced increase in murine mortality from cyclophosphamide. Cancer 1973; 31: 361
   Google Scholar
• Spiegel R J, Pizzo P H, Fantone JC, Zimmerman HJ. Fatal hepatic necrosis after high-dose chemotherapy following haloalkane anaesthesia. Cancer Treat Rep 1980; 64: 1023
   Google Scholar
• Van Dyke RA. Hepatic centrilobular necrosis in rats after exposure to halothane, enflurane, and isoflurane. Anesth Analg 1982; 61: 812
   Google Scholar
• Rosenow S, Kooistra K L, Powis G, Van Dyke RA. Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane. Cancer Chemother Pharmacol 1986; 16: 35
   Google Scholar
• Ueland P M, Refsum H, Wesenberg F, Kvinnsland S. Methotrexate therapy and nitrous oxide anesthesia. N Engl J Med 1986; 314: 1514
   Google Scholar
• Paolini A, D'lncalci M. Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamine. Cancer Treat Rep 1986; 70: 513
   Google Scholar
• Levin V A, Steams J, Byrd A, et al. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), I-(2-chloroethyl)-3-cy-clohexyl-1-nitrosourea (CCNU) and l-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-l-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU. J Pharmacol Exp Ther 1979; 208: 1
   PubMed Web of Science ®Google Scholar
• Hill B, Douglas I, Grover P. Increased antitumor activity of chlorambucil following pretreatment with inducers of drug-metabolizing enzymes. Biochem Pharmacol 1973; 22: 1083
   Google Scholar
• Munson A, Rose W, Bradley S. Synergistic lethal action of alkylating agents and sodium pentobarbital in the mouse. Pharmacology 1974; 11: 231
   Google Scholar
• Bogush T A, Syrkin AB. Effect of phenobarbital and SKF 525-A on the toxic and therapeutic action of adriamycin in mice Ehrlich ascites cancer. Eksp Onkol 1985; 7: 69
   Google Scholar
• Kennedy K A, Hait W N, Lazo JS. Chemical modulation of bleomycin induced toxicity. Int J Radiat Oncol Biol Phys 1986; 12: 1367
   Google Scholar
• Lazo J S, Braun I D, Meand Z B, Kennedy K A, Pham E T, Smaldone LF. Lidocaine potentiation of bleomycin A2 cy-totoxicity and DNA strand breakage in L1210 and human A-253 cells. Cancer Res 1985; 45: 2103
   Google Scholar
• Gieringer J H, Wenz A F, Just H M, Daschner FD. Effect of 5-fluorouracil, mitoxantrone, methotrexate, and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, opiperacillin, and netilmicin. Chemotherapy 1986; 32: 418
   PubMed Web of Science ®Google Scholar
• Henriksson R, Holm S E, Littbrand B. Interactions between antibiotics and antineoplastic drugs on antibacterial activity in vitro. Acta Oncol., In press
   Google Scholar
• Sheldon P W, Clarke C, Dawson K B, Simpson E K, Simmons DJ. Intestinal microflora as potential modifiers of sensitizer activity in vivo. Int J Radiat Biol Phys 1984; 10: 1371
   PubMed Web of Science ®Google Scholar
• Nierenberg DW. Competitive inhibition of methotrexate accumulation in rabbit kidney slices by nonsteroidal antiinflammatory drugs. J Pharmacol Exp Ther 1983; 226: 1
   PubMed Web of Science ®Google Scholar
• Williams W M, Chen T S, Huang KC. Effects of penicillin on the renal tubular secretion of methotrexate in the monkey. Cancer Res 1984; 44: 1913
   Google Scholar
• Iven H, Brasch H. Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits. Cancer Chemother Pharmacol 1986; 17: 218
   PubMed Web of Science ®Google Scholar
• Zager R, Frisby S, Oliverio V. The effect of antibiotics and cancer chemotherapeutic agents in the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia. Cancer Res 1973; 33: 1670
   Google Scholar
• Spector G N, Wang Y M, Gleiser C A, Chan R C, Van Eys J. Effects of gentamicin and irradiation of the toxicity of high-dose methotrexate in rats. Cancer Treat Rep 1980; 64: 989
   Google Scholar
• Gonzales-Vitale J C, Hayes D M, Cvitkovic E, Sternberg SS. Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies. Cancer Treat Rep 1978; 62: 693
   Google Scholar
• Van der Auwera P, Petrikkos G, Husson M, Klastersky P. Influence of various antibiotics on superoxide generation by normal human neutrophils. Arch Int Physiol Biochim 1986; 94: 23
   Google Scholar
• Van Baar H MJ, van der Kerkhof P CM, Mier P D, Happle R. Tetracyclines are potent scavengers of the superoxide radical. Br J Dermatol 1987; 117: 131
   Google Scholar
• Dan M, Shapira I. Possible role of methotrexate in trimetho-prim-sulfamethoxazole-induced acute megaloblastic anemia. Isr J Med Sci 1984; 20: 262
   Google Scholar
• Bellotti M G, Bossa R GI. Interazione tra cefotaxima e adriamicina. G Ital Chemioter 1984; 31: 73
   Google Scholar
• Valeriote F, Medoff G, Cieckman J. Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B1. Cancer Res 1979; 39: 2041
   PubMed Web of Science ®Google Scholar
• Kuwano M, Kamiya T, Endo H, Komiyama S. Potentiation of 5-fluorouracil chromomycin A3, and bleomycin by amphotericin B or polymyxin B in transformed fibroblastic cells. Antimicrob Agents Chemother 1973; 2: 580
   Google Scholar
• Medoff J, Medoff G, Goldstein M N, Schlessinger D, Kobayashi GS. Amphotericin induced sensitivity to actinomycin D in drug-resistant hela cells. Cancer Res 1975; 35: 2548
   PubMed Web of Science ®Google Scholar
• Presant C, Klahr C, Santala R. Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-nitro-sourea (BCNU) plus cyclophosphamide in human neopla-sia. Ann Intern Med 1977; 86: 47
   PubMed Web of Science ®Google Scholar
• Henry N, Bolard J. Synergistic incorporatin of daunorubicin in erythrocytes in the presence of polyene antibiotics. Role of the membrane potential. Biochim Biophys Acta 1986; 16: 84
   Google Scholar
• Clarke G D, Ryan PJ. Tranquilizers can block mitogenesis in 3T3 cells an induce differentiation in Friend cells. Nature 1980; 287: 160
   PubMed Web of Science ®Google Scholar
• Feif C. Diazepam induces mitotic arrest at prometaphase by inhibiting centriolar separation. Nature 1981; 291: 247
   Google Scholar
• Juvekar A S, Chitnis M P, Advani SH. In vitro modulation of adriamycin and mitoxantrone cytotoxicity by hyperthermia and diazepam in human chronic myeloid leukemia cells. Neoplasma 1987; 31: 199
   Google Scholar
• Raichle M E, Hartman B K, Eichling J O, Sharpe LG. Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Nat Acad Sci USA 1975; 72: 3726
   PubMed Web of Science ®Google Scholar
• Heideman R L, Balis F M, Zimm S, Lester C M, Poplack DG. The effect of amitriptyline on the central nervous system penetration of methotrexate. Cancer Drug Deliv 1986; 3: 219
   PubMedGoogle Scholar
• Miyamoto K, Wakusawa S, Yanaoka T, Koshiura R. Studies on enhancement of sensitivity to vinblastine by rauwol-fia alkaloids. Yakugaku Zasshi 1984; 104: 1295
   Google Scholar
• Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Mogami H, Sakamoto Y. Enhancing effect of reserpine upon the cytotoxicity of ACNU on ACNU-resistant glioma cells. Neurol Med Chir 1986; 26: 925
   Google Scholar
• Roemeling R V, Olshefski R, Langevin T, et al. Cisplatin chronotherapy and disulfiram rescue reduce toxicity with out interfering with anticancer activity animal findings and preliminary clinical experiences. Chronobiol Int 1986; 3: 55
   PubMedGoogle Scholar
• Balducci L, Philips M, Wallace C, Hardy C. Cancer chemotherapy in the elderly. Am Fam Physician 1987; 35: 133
   Google Scholar
• Peet M, Middlemiss D N, Yates RA. Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients. Lancet 1980; 2: 978
   Google Scholar